{"id":"W2893294532","doi":"10.1093/ofid/ofy248","title":"Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials","year":2018,"lang":"en","type":"article","venue":"Open Forum Infectious Diseases","topic":"Hepatitis C virus research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa","funders":"Medical Research Council; National Institutes of Health; National Health and Medical Research Council; Sirtex Medical; OPEC Fund for International Development; Johns Hopkins University; Alexion Pharmaceuticals; National Institute on Drug Abuse; Bristol-Myers Squibb; Australian Government; Gilead Sciences; Falk Foundation","keywords":"Ombitasvir; Paritaprevir; Dasabuvir; Medicine; Ritonavir; Internal medicine; Ribavirin; Regimen; Gastroenterology; Hepatitis C; Adverse effect; Hepatitis C virus; Viral load; Virology; Virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01355867,0.001433583,0.005105093,0.0007605325,0.0003815846,0.001791723,0.0006159918,0.0008507967,0.002050018],"category_scores_gemma":[0.008069263,0.0005876083,0.009805459,0.0009894124,0.0009716391,0.0009404285,0.0005813531,0.001652618,0.0002372895],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006106165,"about_ca_system_score_gemma":0.001108379,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004006496,"about_ca_topic_score_gemma":0.001146746,"domain_scores_codex":[0.988062,0.009258474,0.0009888834,0.0007688537,0.000547255,0.0003744481],"domain_scores_gemma":[0.9899671,0.005880945,0.002278816,0.000686729,0.000598322,0.000588071],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.8829182,0.001538452,0.01682327,0.002719429,0.06456864,0.00008872829,0.00007081623,0.001239935,0.002775253,0.00004988696,0.0003231173,0.02688418],"study_design_scores_gemma":[0.4828654,0.247925,0.113946,0.0006869248,0.1423545,0.0004613172,0.0002238358,0.003958544,0.003930348,0.0003968521,0.003112212,0.0001389808],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9714777,0.02483932,0.00069458,0.0002258301,0.0001333327,0.000990205,0.0007637313,0.00003252881,0.0008429154],"genre_scores_gemma":[0.9945315,0.003275426,0.000610657,0.0001410506,0.0001335427,0.000456649,0.0005034162,0.00001451288,0.0003332192],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01355867,"threshold_uncertainty_score":0.07170594,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05050597112412683,"score_gpt":0.3943879352483665,"score_spread":0.3438819641242397,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}